Researchers tracked data from more than 2,000 TAVR patients, focusing on cardiovascular mortality and hospitalizations for heart failure. 

The medication, sold under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.

The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.

The research, presented at EuroPCR 2022 in Paris, represented an updated look at the Optimize PRO study, an ongoing analysis of patients treated with Medtronic’s self-expanding Evolut Pro and Pro+ TAVR systems.

“For patients with cardiovascular disease, abortion access is a critical part of their comprehensive cardiovascular and reproductive care,” according to the three authors of a new commentary piece in JAMA Cardiology.

The new guidance document was designed to provide helpful information on a topic "surrounded by controversy." 

With physician burnout on the rise and a massive physician shortage on the way, it’s more important now than ever to keep a close eye on how the country’s cardiologists—and their colleagues—are being paid. 

American College of Cardiology President Edward T. A. Fry, MD, discusses cardiologist burnout and how the pandemic accelerated the issue.

Gadolinium might be an alternative, stop-gap solution for interventional procedures during the current iodine contrast shortage.